Catalyst Pharmaceuticals Inc’s filing revealed that its Chief Strategy Officer Sundaram Preethi unloaded Company’s shares for reported $61377.0 on Jun
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Catalyst Pharmaceuticals
In a filing, Catalyst Pharmaceuticals Inc revealed its Chief Strategy Officer Sundaram Preethi unloaded Company’s shares for reported $61377.0 on
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Catalyst Pharmaceuticals Inc’s recently made public that its Chief Strategy Officer Sundaram Preethi unloaded Company’s shares for reported $61377.0 on
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Catalyst Pharmaceuticals
In a filing, Catalyst Pharmaceuticals Inc revealed its Chief Strategy Officer Sundaram Preethi unloaded Company’s shares for reported $61377.0 on
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Catalyst Pharmaceuticals
Catalyst Pharmaceuticals Inc’s recently made public that its Chief Strategy Officer Sundaram Preethi unloaded Company’s shares for reported $61377.0 on
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or